Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens.

A. L. Van Eenennaam, Ian Gardner, J. Holmes, L. Perani, R. J. Anderson, James S Cullor, W. M. Guterbock

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

For two large California dairy herds with twice daily milking, 171 infected quarters of lactating cows with mild clinical mastitis were randomly assigned to one of three treatment groups. Group A (50 cows) was treated with 62.5 mg of intramammary amoxicillin every 12 h for three milkings. Group C (50 cows) was treated with 200 mg of intramammary cephapirin every 12 h for two milkings. Group O (71 cows) was treated with 100 U of intramuscular oxytocin every 12 h for three milkings. Clinical cure rates did not differ among treatment groups. The cost per episode of clinical mastitis was higher ($54.47) for group C than for groups A ($38.53) or O ($34.88). Group O had a higher incidence of relapse (41%), and a greater percentage of group O cows (65%) experienced an additional mastitic event in the enrolled lactation than did cows in groups A and C. Treatment had no effect on the mean number of nonsalable milkings (24.7) associated with mastitis in the lactation interval subsequent to enrollment on the trial. Twenty-two percent of the cows accrued more than 30 nonsalable milkings and produced 55% of the total nonsalable milkings associated with mastitis. There was no treatment effect on total milk production, fat production, or time to removal of the enrolled cows from the herd.

Original languageEnglish (US)
Pages (from-to)2086-2095
Number of pages10
JournalJournal of Dairy Science
Volume78
Issue number9
StatePublished - Sep 1995

Fingerprint

Mastitis
mastitis
milking
cows
pathogens
Lactation
Cephapirin
Amoxicillin
Oxytocin
Milk
lactation
Fats
cephapirin
Costs and Cost Analysis
Recurrence
amoxicillin
oxytocin
Incidence
relapse
dairy herds

ASJC Scopus subject areas

  • Animal Science and Zoology
  • veterinary(all)
  • Food Science

Cite this

Van Eenennaam, A. L., Gardner, I., Holmes, J., Perani, L., Anderson, R. J., Cullor, J. S., & Guterbock, W. M. (1995). Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens. Journal of Dairy Science, 78(9), 2086-2095.

Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens. / Van Eenennaam, A. L.; Gardner, Ian; Holmes, J.; Perani, L.; Anderson, R. J.; Cullor, James S; Guterbock, W. M.

In: Journal of Dairy Science, Vol. 78, No. 9, 09.1995, p. 2086-2095.

Research output: Contribution to journalArticle

Van Eenennaam, AL, Gardner, I, Holmes, J, Perani, L, Anderson, RJ, Cullor, JS & Guterbock, WM 1995, 'Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens.', Journal of Dairy Science, vol. 78, no. 9, pp. 2086-2095.
Van Eenennaam, A. L. ; Gardner, Ian ; Holmes, J. ; Perani, L. ; Anderson, R. J. ; Cullor, James S ; Guterbock, W. M. / Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens. In: Journal of Dairy Science. 1995 ; Vol. 78, No. 9. pp. 2086-2095.
@article{6d51b1c559a849dea887d509659e0da2,
title = "Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens.",
abstract = "For two large California dairy herds with twice daily milking, 171 infected quarters of lactating cows with mild clinical mastitis were randomly assigned to one of three treatment groups. Group A (50 cows) was treated with 62.5 mg of intramammary amoxicillin every 12 h for three milkings. Group C (50 cows) was treated with 200 mg of intramammary cephapirin every 12 h for two milkings. Group O (71 cows) was treated with 100 U of intramuscular oxytocin every 12 h for three milkings. Clinical cure rates did not differ among treatment groups. The cost per episode of clinical mastitis was higher ($54.47) for group C than for groups A ($38.53) or O ($34.88). Group O had a higher incidence of relapse (41{\%}), and a greater percentage of group O cows (65{\%}) experienced an additional mastitic event in the enrolled lactation than did cows in groups A and C. Treatment had no effect on the mean number of nonsalable milkings (24.7) associated with mastitis in the lactation interval subsequent to enrollment on the trial. Twenty-two percent of the cows accrued more than 30 nonsalable milkings and produced 55{\%} of the total nonsalable milkings associated with mastitis. There was no treatment effect on total milk production, fat production, or time to removal of the enrolled cows from the herd.",
author = "{Van Eenennaam}, {A. L.} and Ian Gardner and J. Holmes and L. Perani and Anderson, {R. J.} and Cullor, {James S} and Guterbock, {W. M.}",
year = "1995",
month = "9",
language = "English (US)",
volume = "78",
pages = "2086--2095",
journal = "Journal of Dairy Science",
issn = "0022-0302",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens.

AU - Van Eenennaam, A. L.

AU - Gardner, Ian

AU - Holmes, J.

AU - Perani, L.

AU - Anderson, R. J.

AU - Cullor, James S

AU - Guterbock, W. M.

PY - 1995/9

Y1 - 1995/9

N2 - For two large California dairy herds with twice daily milking, 171 infected quarters of lactating cows with mild clinical mastitis were randomly assigned to one of three treatment groups. Group A (50 cows) was treated with 62.5 mg of intramammary amoxicillin every 12 h for three milkings. Group C (50 cows) was treated with 200 mg of intramammary cephapirin every 12 h for two milkings. Group O (71 cows) was treated with 100 U of intramuscular oxytocin every 12 h for three milkings. Clinical cure rates did not differ among treatment groups. The cost per episode of clinical mastitis was higher ($54.47) for group C than for groups A ($38.53) or O ($34.88). Group O had a higher incidence of relapse (41%), and a greater percentage of group O cows (65%) experienced an additional mastitic event in the enrolled lactation than did cows in groups A and C. Treatment had no effect on the mean number of nonsalable milkings (24.7) associated with mastitis in the lactation interval subsequent to enrollment on the trial. Twenty-two percent of the cows accrued more than 30 nonsalable milkings and produced 55% of the total nonsalable milkings associated with mastitis. There was no treatment effect on total milk production, fat production, or time to removal of the enrolled cows from the herd.

AB - For two large California dairy herds with twice daily milking, 171 infected quarters of lactating cows with mild clinical mastitis were randomly assigned to one of three treatment groups. Group A (50 cows) was treated with 62.5 mg of intramammary amoxicillin every 12 h for three milkings. Group C (50 cows) was treated with 200 mg of intramammary cephapirin every 12 h for two milkings. Group O (71 cows) was treated with 100 U of intramuscular oxytocin every 12 h for three milkings. Clinical cure rates did not differ among treatment groups. The cost per episode of clinical mastitis was higher ($54.47) for group C than for groups A ($38.53) or O ($34.88). Group O had a higher incidence of relapse (41%), and a greater percentage of group O cows (65%) experienced an additional mastitic event in the enrolled lactation than did cows in groups A and C. Treatment had no effect on the mean number of nonsalable milkings (24.7) associated with mastitis in the lactation interval subsequent to enrollment on the trial. Twenty-two percent of the cows accrued more than 30 nonsalable milkings and produced 55% of the total nonsalable milkings associated with mastitis. There was no treatment effect on total milk production, fat production, or time to removal of the enrolled cows from the herd.

UR - http://www.scopus.com/inward/record.url?scp=0029363716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029363716&partnerID=8YFLogxK

M3 - Article

C2 - 8550918

AN - SCOPUS:0029363716

VL - 78

SP - 2086

EP - 2095

JO - Journal of Dairy Science

JF - Journal of Dairy Science

SN - 0022-0302

IS - 9

ER -